V512 + Comparator: Placebo to V512
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza
Conditions
Influenza
Trial Timeline
Oct 1, 2006 → Jan 1, 2009
NCT ID
NCT00851266About V512 + Comparator: Placebo to V512
V512 + Comparator: Placebo to V512 is a phase 1 stage product being developed by Merck for Influenza. The current trial status is completed. This product is registered under clinical trial identifier NCT00851266. Target conditions include Influenza.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00851266 | Phase 1 | Completed |
Competing Products
20 competing products in Influenza